Back to Treatments

Treatment

Gemcitabine monotherapy

1
Conditions
65
Trials
10K
Participants
30%
Average Safety

Condition Evidence

Pancreatic cancer

65 trials · 10K participants

65% effectiveness · 30% safety
Gemcitabine monotherapy | DFDA